Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Clinical significance of metallothioneins in cell therapy and nanomedicine.

Sharma S, Rais A, Sandhu R, Nel W, Ebadi M.

Int J Nanomedicine. 2013;8:1477-88. doi: 10.2147/IJN.S42019. Epub 2013 Apr 16. Review.

2.

Significance of metallothioneins in aging brain.

Sharma S, Ebadi M.

Neurochem Int. 2014 Jan;65:40-8. doi: 10.1016/j.neuint.2013.12.009. Epub 2014 Jan 3. Review.

PMID:
24389356
3.
4.

Non-enzymatic modifications in metallothioneins connected to lipid membrane damages: structural and biomimetic studies under reductive radical stress.

Torreggiani A, Chatgilialoglu C, Ferreri C, Melchiorre M, Atrian S, Capdevila M.

J Proteomics. 2013 Oct 30;92:204-15. doi: 10.1016/j.jprot.2013.02.005. Epub 2013 Mar 28.

PMID:
23542714
5.

Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

Ebadi M, Brown-Borg H, El Refaey H, Singh BB, Garrett S, Shavali S, Sharma SK.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):67-75. Review.

6.

Antioxidant and antiapoptotic function of metallothioneins in HL-60 cells challenged with copper nitrilotriacetate.

Kawai K, Liu SX, Tyurin VA, Tyurina YY, Borisenko GG, Jiang JF, St Croix CM, Fabisiak JP, Pitt BR, Kagan VE.

Chem Res Toxicol. 2000 Dec;13(12):1275-86.

PMID:
11123969
7.

Biomarkers in Parkinson's disease (recent update).

Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Ojo C, Jelebinkov M, Kurdi Y, Ebadi M.

Neurochem Int. 2013 Sep;63(3):201-29. doi: 10.1016/j.neuint.2013.06.005. Epub 2013 Jun 19. Review.

PMID:
23791710
8.

Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs.

Sabolić I, Breljak D, Skarica M, Herak-Kramberger CM.

Biometals. 2010 Oct;23(5):897-926. doi: 10.1007/s10534-010-9351-z. Epub 2010 Jun 15. Review.

PMID:
20549307
9.

Microarray analysis of metallothioneins in human diseases--A review.

Krizkova S, Kepinska M, Emri G, Rodrigo MA, Tmejova K, Nerudova D, Kizek R, Adam V.

J Pharm Biomed Anal. 2016 Jan 5;117:464-73. doi: 10.1016/j.jpba.2015.09.031. Epub 2015 Sep 30. Review.

PMID:
26454339
10.

Metallothioneins in the lung cancer.

Werynska B, Pula B, Kobierzycki C, Dziegiel P, Podhorska-Okolow M.

Folia Histochem Cytobiol. 2015;53(1):1-10. doi: 10.5603/FHC.a2015.0009. Epub 2015 Mar 27. Review.

11.

Nanotheranostics in evidence based personalized medicine.

Sharma S.

Curr Drug Targets. 2014;15(10):915-30. Review.

PMID:
25174340
12.

Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.

Ebadi M, Sharma SK, Ghafourifar P, Brown-Borg H, El Refaey H.

Methods Enzymol. 2005;396:276-98.

PMID:
16291239
13.

The stoichiometric transition from Zn6Cu1-metallothionein to Zn7-metallothionein underlies the up-regulation of metallothionein (MT) expression: quantitative analysis of MT-metal load in eye cells.

Alvarez L, Gonzalez-Iglesias H, Garcia M, Ghosh S, Sanz-Medel A, Coca-Prados M.

J Biol Chem. 2012 Aug 17;287(34):28456-69. doi: 10.1074/jbc.M112.365015. Epub 2012 Jun 21.

14.

Metallothioneins (MTs) in the human eye: a perspective article on the zinc-MT redox cycle.

Gonzalez-Iglesias H, Alvarez L, García M, Petrash C, Sanz-Medel A, Coca-Prados M.

Metallomics. 2014 Feb;6(2):201-8. doi: 10.1039/c3mt00298e. Review.

PMID:
24419560
15.

Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies.

Okita Y, Rcom-H'cheo-Gauthier AN, Goulding M, Chung RS, Faller P, Pountney DL.

Front Neurosci. 2017 Apr 4;11:114. doi: 10.3389/fnins.2017.00114. eCollection 2017. Review.

16.

Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.

Ostrakhovitch EA, Song YP, Cherian MG.

J Trace Elem Med Biol. 2016 May;35:18-29. doi: 10.1016/j.jtemb.2016.01.008. Epub 2016 Jan 22.

PMID:
27049123
17.

Metallothioneins, oxidative stress and the cardiovascular system.

Nath R, Kumar D, Li T, Singal PK.

Toxicology. 2000 Nov 30;155(1-3):17-26. Review.

PMID:
11154793
18.

Expression and regulation of brain metallothionein.

Ebadi M, Iversen PL, Hao R, Cerutis DR, Rojas P, Happe HK, Murrin LC, Pfeiffer RF.

Neurochem Int. 1995 Jul;27(1):1-22. Review.

PMID:
7655341
19.

Role of metallothionein in murine experimental colitis.

Tsuji T, Naito Y, Takagi T, Kugai M, Yoriki H, Horie R, Fukui A, Mizushima K, Hirai Y, Katada K, Kamada K, Uchiyama K, Handa O, Konishi H, Yagi N, Ichikawa H, Yanagisawa R, Suzuki JS, Takano H, Satoh M, Yoshikawa T.

Int J Mol Med. 2013 May;31(5):1037-46. doi: 10.3892/ijmm.2013.1294. Epub 2013 Mar 6.

PMID:
23467591
20.

Oxidation and turnover of renal metallothioneins after an injection of ferric nitrilotriacetate.

Min KS, Kishi N, Yamashita N, Tanaka K.

Chem Biol Interact. 2012 Jan 5;195(1):61-7. doi: 10.1016/j.cbi.2011.09.006. Epub 2011 Oct 4.

PMID:
22001350

Supplemental Content

Support Center